Comprehensive Financial Consultants Institutional’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
16,575
-298
| -2% | -$20.8K | 0.38% | 85 |
|
|
2025
Q1 | $1.24M | Buy |
16,873
+243
| +1% | +$17.9K | 0.44% | 79 |
|
|
2024
Q4 | $1.09M | Sell |
16,630
-353
| -2% | -$23.1K | 0.4% | 85 |
|
|
2024
Q3 | $1.32M | Sell |
16,983
-869
| -5% | -$67.7K | 0.48% | 74 |
|
|
2024
Q2 | $1.39M | Buy |
17,852
+1,395
| +8% | +$109K | 0.55% | 71 |
|
|
2024
Q1 | $1.11M | Buy |
16,457
+762
| +5% | +$51.6K | 0.46% | 78 |
|
|
2023
Q4 | $1.06M | Buy |
15,695
+389
| +3% | +$26.2K | 0.49% | 78 |
|
|
2023
Q3 | $1.04M | Sell |
15,306
-171
| -1% | -$11.6K | 0.54% | 71 |
|
|
2023
Q2 | $1.04M | Buy |
15,477
+243
| +2% | +$16.3K | 0.55% | 70 |
|
|
2023
Q1 | $1.06M | Sell |
15,234
-218
| -1% | -$15.1K | 0.6% | 66 |
|
|
2022
Q4 | $1.08M | Buy |
15,452
+105
| +0.7% | +$7.36K | 0.65% | 58 |
|
|
2022
Q3 | $862K | Buy |
15,347
+1,245
| +9% | +$69.9K | 0.57% | 63 |
|
|
2022
Q2 | $940K | Sell |
14,102
-83
| -0.6% | -$5.53K | 0.67% | 56 |
|
|
2022
Q1 | $913K | Buy |
+14,185
| New | +$913K | 0.64% | 58 |
|